HALO Results | HALO Message Board Posts


Halozyme Therapeutics, Inc.

  HALO website

HALO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  799 of 807  at  11/3/2021 10:56:51 AM  by

Biotech2050


 In response to msg 798 by  ladcad
view thread

Re: HALO Results

 Helen needs to stop sitting on her laurels and acquires a platform as Enhanze subcutaneous patent expires in 2027.
 
Actinium Pharmaceuticals ATNM would be a perfect fit. The joint platforms would create patentable co-formulations through 2030.
 
 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 1  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...